Receptors involved in moxonidine-stimulated atrial natriuretic peptide release from isolated normotensive rat hearts

European Journal of Pharmacology

Volumn 541, Issue 1-2, 2006, Pages 73-79

  Mukaddam Daher, Suhayla ^a   Menaouar, Ahmed ^a   Gutkowska, Jolanta ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

2 adrenoceptors; Atrial natriuretic peptide; Heart; Imidazoline receptors; Moxonidine; Perfusion

Indexed keywords

AGN 192403; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ATRIAL NATRIURETIC FACTOR; BRIMONIDINE; BUFFER; CLONIDINE; IMIDAZOLINE I1 RECEPTOR; MOXONIDINE; PHENOXYBENZAMINE; PRAZOSIN; RAUWOLSCINE; RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG;

ADRENERGIC ACTIVITY; ANIMAL TISSUE; ARTICLE; BRADYCARDIA; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DILATATION; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; FEMALE; HEART PERFUSION; ISOLATED HEART; NONHUMAN; PRIORITY JOURNAL; RAT; STATISTICAL SIGNIFICANCE;

ADRENERGIC ALPHA-2 RECEPTOR AGONISTS; ADRENERGIC ALPHA-2 RECEPTOR ANTAGONISTS; ADRENERGIC ALPHA-AGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; ANTIHYPERTENSIVE AGENTS; ATRIAL NATRIURETIC FACTOR; BICYCLO COMPOUNDS; CLONIDINE; CORONARY CIRCULATION; DRUG SYNERGISM; FEMALE; HEART; HEART RATE; HEPTANES; IMIDAZOLES; IMIDAZOLINE RECEPTORS; MYOCARDIUM; PERFUSION; PHENOXYBENZAMINE; PRAZOSIN; QUINOXALINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, ALPHA-2; RECEPTORS, DRUG; YOHIMBINE;

EID: 33745162244     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.05.009     Document Type: Article

References (30)

1. Akers W.S., Shah S.K., Flynn J.D., and Apparsundaram S. Effect of clonidine on cardiac norepinephrine spillover in isolated rat heart. J. Cardiovasc. Pharmacol. 43 (2004) 830-838
2. Ambler S.K., and Leite M.F. Regulation of atrial natriuretic peptide secretion by alpha 1-adrenergic receptors: the role of different second messenger pathways. J. Mol. Cell. Cardiol. 26 (1994) 391-402
3. Anand-Srivastava M. Natriuretic peptide receptor-C signaling and regulation. Peptides 26 (2005) 1044-1059
4. Carvajal J.A., Germain A.M., Huidobro-Toro J.P., and Weiner C.P. Molecular mechanism of cGMP-mediated smooth muscle relaxation. J. Cell. Physiol. 184 (2000) 409-420
5. Chlopicki S., Kozlovski V.I., and Gryglewski R.J. Clonidine-induced coronary vasodilatation in isolated guinea pig heart is not mediated by endothelial A2 adrenoceptors. J. Physiol. Pharmacol. 54 (2003) 511-521
6. Drewett J.G., Trachte G.J., and Marchand G.R. Atrial natriuretic factor inhibits adrenergic and purinergic neurotransmission in the rabbit isolated vas deferens. J. Pharmacol. Exp. Ther. 248 (1989) 135-142
7. Drewett J.G., Ziegler R.J., and Trachte G.J. Neuromodulatory effects of atrial natriuretic peptides correlate with an inhibition of adenylate cyclase but not an activation of guanylate cyclase. J. Pharmacol. Exp. Ther. 260 (1992) 689-696
8. El-Ayoubi R., Gutkowska J., Regunathan S., and Mukaddam-Daher S. Imidazoline receptors in the heart: characterization, distribution, and regulation. J. Cardiovasc. Pharmacol. 39 (2002) 875-883
9. El-Ayoubi R., Menaouar A., Gutkowska J., and Mukaddam-Daher S. Imidazoline receptors but not alpha2 adrenoceptors are regulated in SHR heart by chronic moxonidine treatment. J. Pharmacol. Exp. Ther. 310 (2004) 446-451
10. El-Ayoubi R., Menaouar A., Gutkowska J., and Mukaddam-Daher S. Urinary responses to acute moxonidine are inhibited by natriuretic peptide receptor antagonist. Br. J. Pharmacol. 145 (2005) 50-56
11. Gu J. Immunocytochemical detection of atrial natriuretic peptide in periarterial myocardiocytes of cardiac ventricles of adult normotensive rat. J. Histochem. Cytochem. 39 (1991) 829-834
12. Gutkowska J. Radioimmunoassay for atrial natriuretic factor. Nucl. Med. Biol. 14 (1987) 323-331
13. 1-imidazoline receptors in the rostral ventrolateral medulla. J. Cardiovasc. Pharmacol. 24 supp I (1994) S1-S8
14. Hirakata H., and Fouad-Tarazi F.M. The differential effects of alpha 2-adrenergic stimulation on the myocardium and coronary vessels in the isolated rat heart. Life Sci. 43 (1988) 2025-2033
15. Lambert C., Mossiat C., Tanniere-Zeller M., Maupoil V., and Rochette L. Antiarrhythmic effect of amiodarone on doxorubicin acute toxicity in working rat hearts. Cardiovasc. Res. 24 (1990) 653-658
16. Li D., Wen J.F., Jin J.Y., Jin H., Ann H.S., Kim S.Z., Kim S.H., Lee H.S., and Cho K.W. Histamine inhibits atrial myocytic ANP release via H2 receptor-cAMP-protein kinase signaling. Am. J. Physiol., Regul. Integr. Comp. Physiol. 285 (2003) R380-R393
17. McAllen R.M., May C.N., and Campos R.R. The supply of vasomotor drive to individual classes of sympathetic neuron. Clin. Exp. Hypertens. 19 (1997) 607-618
18. Melo L.G., Veress A.T., Ackermann U., Pang S.C., Flynn T.G., and Sonnenberg H. Chronic hypertension in ANP knockout mice: contribution of peripheral resistance. Regul. Pept. 79 (1999) 109-115
19. Mukaddam-Daher S., and Gutkowska J. The renal actions of moxonidine are mediated by atrial natriuretic peptide and involve the opioid receptors. Ann. N.Y. Acad. Sci. 881 (1999) 385-387
20. Mukaddam-Daher S., and Gutkowska J. Atrial natriuretic peptide is involved in the renal actions of moxonidine. Hypertension 35 (2000) 215-220
21. Mukaddam-Daher S., Lambert C., and Gutkowska J. Clonidine and ST-91 may activate imidazoline binding sites in the heart to release atrial natriuretic peptide. Hypertension 30 (1997) 83-87
22. Munk S.A., Lai R.K., Burke J.E., Arasasingham P.N., Kharlamb A.B., Manlapaz C.A., Padillo E.U., Wijono M.K., Hasson D.W., Wheeler L.A., and Garst M.E. Synthesis and pharmacologic evaluation of 2-endo-amino-3-exo-isopropylbicyclo[2.2.1]heptane: a potent imidazoline1 receptor specific agent. J. Med. Chem. 39 (1996) 193-195
23. Ogidigben M.J., Chu T.C., and Potter D.E. Naphazoline-induced neuroendocrine changes: increases in ANP and cGMP levels, but suppression of NE, 3H-NE, and cAMP levels in rabbit eyes. Pharmacology 65 (2002) 155-161
24. Pompermayer K., Salgado M.C., Feldman J., and Bousquet P. Cardiovascular effects of clonidine-like drugs in pithed rabbits. Hypertension 34 (1999) 1012-1015
25. Raasch W., Chun K.R.J., Dendorfer A., and Dominiak P. Positive inotropic effects of imidazoline derivatives are not mediated via imidazoline binding sites but alpha1-adrenergic receptors. Jpn. J. Pharmacol. 84 (2000) 1-6
26. Raasch W., Jungbluth B., Schafer U., Hauser W., and Dominiak P. Modification of noradrenaline release in pithed spontaneously hypertensive rats by I1-binding sites in addition to alpha2-adrenoceptors. J. Pharmacol. Exp. Ther. 304 (2003) 1063-1071
27. Schafer U., Burgdorf C., Engelhardt A., Kurz T., and Richardt G. Presynaptic effects of moxonidine in isolated buffer perfused rat hearts: role of imidazoline-1 receptors and alpha2-adrenoceptors. J. Pharmacol. Exp. Ther. 303 (2002) 1163-1170
28. Schafer U., Burgdorf C., Engelhardt A., Raasch W., Kurz T., and Richardt G. Moxonidine displays a presynaptic alpha-2-adrenoceptor-dependent synergistic sympathoinhibitory action at imidazoline-1 receptors. Ann. N.Y. Acad. Sci. 1009 (2003) 265-269
29. Szabo B., Bock C., Nordheim U., and Niederhoffer N. Mechanism of the sympatho-inhibition produced by the clonidine-like drugs rilmenidine and moxonidine. Ann. N.Y. Acad. Sci. 881 (1999) 253-264
30. Vollmar A.M. The role of atrial natriuretic peptide in the immune system. Peptides 26 (2005) 1086-1094